Parse Biosciences, founded in 2018, is a biotechnology company that aims to provide researchers with single-cell solutions to streamline their experiments and discovery for objectives such as cancer treatment and stem cell therapy. Their Evercode products seek to use single-cell technology for gene capture at a greater scale and advanced data evaluation that strive to make it easier for researchers to quickly analyze results, all without having to use an instrument. Parse Biosciences is headquartered in Seattle, Washington.

Register To Buy and Sell Shares

For more details on financing and valuation for Parse Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Parse Biosciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Parse Biosciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Alexander Rosenberg Ph.D
Co-Founder & Chief Executive Officer
Britton Russell
Chief Financial Officer
Charlie Roco Ph.D
Co-Founder & Chief Technology Officer
Georg Seelig

Parse Biosciences’ stock FAQs


Can you buy Parse Biosciences’ stock?

Parse Biosciences is not publicly traded on NYSE or NASDAQ in the U.S. To buy Parse Biosciences’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Parse Biosciences’ stock?

Yes, you can sell stock of a private company like Parse Biosciences. Forge can help you sell your Parse Biosciences stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Parse Biosciences’ stock price?

Parse Biosciences is a privately held company and therefore does not have a public stock price. However, you may access Parse Biosciences’ private market stock price with Forge Data.

What is Parse Biosciences’ stock ticker symbol?

Parse Biosciences does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Parse Biosciences Closes $50M in Funding

Parse Biosciences, a Seattle, WA-based provider of scalable single cell sequencing solutions, raised $50M in financing from a Series C equity and the closing of a debt facility. Soleus Capital led the Series C equity financing, with participation from new and current investors including Bioeconomy Capital, Janus Henderson Investors, Marshall Wace, Sahsen Ventures, and Saras Capital. Horizon Technology Finance Corporation (Nasdaq: HRZN) provided the debt facility. It brought the company’s total funding to over $100M.
Updated on: Jun 22, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.